Submitted by Anonymous (not verified) on 5 June 2026 - 9:31
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tivdak, tisotumab vedotin, Date of authorisation: 28/03/2025, Revision: 4, Status: Authorised